Bill > HR3091

This bill amends the Internal Revenue Code to expand what can be considered a medical expense for Health Savings Accounts (HSAs), specifically by including fertility treatments. The bill defines fertility treatments broadly to encompass a wide range of reproductive medical services, including: preserving and storing reproductive genetic material like eggs, sperm, and embryos; various types of artificial insemination techniques (intravaginal, intracervical, and intrauterine); assisted reproductive technologies like in vitro fertilization; fertility-related medications; and gamete donation, including reimbursement for donors and associated medical expenses. By making these treatments eligible expenses for HSAs, the bill aims to make fertility treatments more financially accessible by allowing individuals to use pre-tax health savings account funds to cover these often expensive medical services. The amendments would apply to amounts paid after the bill's enactment, and the legislation explicitly states that this change should not be construed as creating any inference about previous fertility-related expenses or limiting the existing treatment of other fertility-related expenses as medical costs.

Budget and Finance

https://www.congress.gov/bill/119th-congress/house-bill/3091/all-info